11.72
Nextcure Inc (NXTC) 最新ニュース
Analyzing Monte Rosa Therapeutics (NASDAQ:GLUE) and NextCure (NASDAQ:NXTC) - Defense World
Is NextCure Inc. stock a buy on dips2025 Market WrapUp & Stock Market Timing Techniques - Улправда
Breakouts Watch: What margin trends mean for NextCure Inc. stockQuarterly Risk Review & Free Technical Pattern Based Buy Signals - Улправда
NextCure Launches At-The-Market Stock Offering Program - TipRanks
NextCure Enters ATM Offering Agreement - TradingView — Track All Markets
Will NextCure Inc. stock remain a Wall Street favorite2025 Key Highlights & Daily Profit Maximizing Tips - DonanımHaber
Will NextCure Inc. stock maintain growth storyQuarterly Market Summary & Verified Momentum Stock Watchlist - DonanımHaber
What margin trends mean for NextCure Inc. stockJuly 2025 Short Interest & High Return Trade Guides - Улправда
Is NextCure Inc. stock positioned well for digital economyQuarterly Trade Review & Long Hold Capital Preservation Plans - DonanımHaber
Aug Mood: Is NextCure Inc. stock a buy on dipsJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда
Swing Trade: Is NextCure Inc. stock a buy on dips2025 Earnings Impact & Weekly Stock Breakout Alerts - Улправда
Death Cross: Can NextCure Inc. stock surprise with earnings upsideJuly 2025 Analyst Calls & Stock Portfolio Risk Management - Улправда
Can NextCure Inc. stock surprise with earnings upsideWeekly Trade Recap & Technical Pattern Based Signals - Улправда
NextCure (NASDAQ:NXTC) Upgraded to “Hold” at Wall Street Zen - Defense World
What sentiment indicators say about NextCure Inc. stockStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
How analysts rate NextCure Inc. stock todayJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser
What is the fair value of NextCure Inc. stock nowJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Will NextCure Inc. stock deliver long term returnsWeekly Profit Report & High Return Trade Guides - Newser
NextCure stock plunges to 52-week low, hits $0.69 - MSN
NextCure files for offering of up to 2.52 million shares of common stock by selling stockholdersSEC filing - marketscreener.com
[S-3] NextCure, Inc. Shelf Registration Statement | NXTC SEC FilingForm S-3 - Stock Titan
Piper Sandler Keeps Their Buy Rating on NextCure (NXTC) - theglobeandmail.com
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - The Globe and Mail
NextCure (Nasdaq: NXTC) in fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan
NextCure Raises $21.5M in Private Placement - MSN
Will NextCure Inc. stock maintain momentum in 2025Trade Entry Summary & Reliable Trade Execution Plans - newser.com
Can NextCure Inc. stock sustain market leadershipQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
FY2025 EPS Estimates for NextCure Boosted by HC Wainwright - Defense World
How currency fluctuations impact NextCure Inc. stockEarnings Overview Report & Precise Buy Zone Tips - newser.com
How NextCure Inc. stock reacts to inflationary pressuresJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
NextCure Inc. recovery potential after sell offMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Will NextCure Inc. stock gain from lower inflationProfit Target & AI Enhanced Trading Alerts - newser.com
Evaluating NextCure Inc. with trendline analysisEarnings Growth Report & Real-Time Volume Analysis - newser.com
Comparing NextCure Inc. in custom built stock radarsJuly 2025 Sector Moves & Low Volatility Stock Recommendations - newser.com
A activityJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
NextCure secures $21.5 million in private placement to extend cash runway - Investing.com Canada
NextCure, Inc. Secures $21.5 Million in Private Placement, Extending Cash Runway into First Half of 2027 - Quiver Quantitative
NextCure (Nasdaq: NXTC) PIPE Extends Runway to 1H 2027 Ahead of 2026 ADC POC Data - Stock Titan
How to integrate NextCure Inc. into portfolio analysis toolsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
NextCure, Inc. announced that it has received $21.498209 million in funding from Ikarian Capital, LLC, Squadron Capital Management Llc, Affinity Asset Advisors, LLC, Exome Asset Management LLC - MarketScreener
大文字化:
|
ボリューム (24 時間):